Your browser doesn't support javascript.
loading
Long-term survival analysis of addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancer.
Iwase, Madoka; Ando, Masashi; Aogi, Kenjiro; Aruga, Tomoyuki; Inoue, Kenichiro; Shimomura, Akihiko; Tokunaga, Eriko; Masuda, Norikazu; Yamauchi, Hideko; Yamashita, Toshinari; Iwata, Hiroji.
Afiliación
  • Iwase M; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, 464-8681, Japan.
  • Ando M; Division of Cancer Epidemiology and Prevention, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Aogi K; Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
  • Aruga T; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan. mandoh@aichi-cc.jp.
  • Inoue K; Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
  • Shimomura A; Department of Breast Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Tokunaga E; Division of Breast Oncology, Saitama Cancer Center, Saitama, Japan.
  • Masuda N; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Yamauchi H; Department of Breast Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Yamashita T; Division of Breast, Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan.
  • Iwata H; Department of Breast Surgical Oncology, St. Luke's International Hospital, Tokyo, Japan.
Breast Cancer Res Treat ; 180(3): 687-694, 2020 Apr.
Article en En | MEDLINE | ID: mdl-32140811
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Quimioterapia Adyuvante / Receptor ErbB-2 / Terapia Neoadyuvante Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Año: 2020 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Quimioterapia Adyuvante / Receptor ErbB-2 / Terapia Neoadyuvante Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Año: 2020 Tipo del documento: Article País de afiliación: Japón